Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Sell
9,305
-23,789
-72% -$2.75M 0.04% 352
2025
Q4
$3.48M Buy
33,094
+23,061
+230% +$2.16M 0.12% 125
2025
Q3
$842K Sell
10,033
-2,852
-22% -$235K 0.03% 497
2025
Q2
$1.02M Sell
12,885
-13,592
-51% -$1.08M 0.05% 352
2025
Q1
$2.38M Buy
26,477
+12,237
+86% +$1.14M 0.1% 148
2024
Q4
$1.42M Buy
14,240
+1,026
+8% +$106K 0.07% 223
2024
Q3
$1.5M Sell
13,214
-14,980
-53% -$1.78M ﹤0.01% 1793
2024
Q2
$3.49M Buy
28,194
+25,218
+847% +$3.25M 0.01% 1099
2024
Q1
$393K Sell
2,976
-39,277
-93% -$4.84M ﹤0.01% 2774
2023
Q4
$4.61M Buy
42,253
+35,623
+537% +$3.7M 0.01% 1065
2023
Q3
$683K Buy
+6,630
New +$715K ﹤0.01% 2314

Other funds holding MRK

GTS Securities's MRK Position: Q1 2026 in Review

GTS Securities reduced its Merck (MRK) stake by 72% in Q1 2026, selling an estimated $2.75M and leaving 9,305 shares worth $1.12M. The position accounts for 0.04% of the portfolio, ranked #352.

GTS Securities first reported a position in MRK in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.61M in Q4 2023. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • GTS Securities held 9,305 shares of Merck worth $1.12M as of Q1 2026.
  • GTS Securities sold 23,789 Merck shares in Q1 2026, an estimated $2.75M.
  • Merck made up 0.04% of GTS Securities's portfolio in Q1 2026, its #352 holding.
  • GTS Securities first reported a position in Merck in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Merck position peaked at $4.61M in Q4 2023.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.